![MathJax Logo](/templates/jsp/_style2/_tandf/pb2/images/math-jax.gif)
Abstract
In this paper, a deterministic model characterizing the within-host infection of Hepatitis C virus (HCV) in intrahepatic and extrahepatic tissues is presented. In addition, the model also includes the effect of the cytotoxic T lymphocyte (CTL) immunity described by a linear activation rate by infected cells. Firstly, the non-negativity and boundedness of solutions of the model are established. Secondly, the basic reproduction number and immune reproduction number
are calculated, respectively. Three equilibria, namely, infection-free, CTL immune response-free and infected equilibrium with CTL immune response are discussed in terms of these two thresholds. Thirdly, the stability of these three equilibria is investigated theoretically as well as numerically. The results show that when
, the virus will be cleared out eventually and the CTL immune response will also disappear; when
, the virus persists within the host, but the CTL immune response disappears eventually; when
, both of the virus and the CTL immune response persist within the host. Finally, a brief discussion will be given.
1. Introduction
Viral hepatitis affects approximately 500 million people around the world – more than 10 times the number affected by HIV/AIDS [Citation1]. Different viruses can cause various forms of viral hepatitis. It is estimated that about 71 million people or 1% of the global population are chronically infected with hepatitis C according to the World Health Organization(WHO) Global Hepatitis Report in 2017 [Citation21]. Therefore, it is important to understand the dynamics of HCV infection in order to manage control programmes efficiently.
Hepatitis C virus (HCV) infection can lead to two different outcomes [Citation8]: in a small fraction of patients (15% of cases), the infection can be controlled and cleared from the blood; the rest of the patients become chronic. Chronic HCV is the main cause of chronic liver diseases and cirrhosis leading to liver transplantation (LT) or death [Citation2]. Unfortunately, the early results of transplantation for patients with chronic HCV were discouraging. Mortality rate of liver transplant is very high, and reinfection of the liver graft often occurs [Citation20]. This inevitable post-transplant infection may be related to the existence of an auxiliary compartment [Citation11]. The presence of HCV replicative intermediates has been reported in serum [Citation7], oral mucosa [Citation3] and gastric mucosa [Citation5]. Dahari et al. [Citation4] studied viral loads of 30 patients undergoing liver transplantation and observed the existence of a second replication compartment.
Virus clearance after acute HCV infection is associated with strong and polyclonal CD4 T cell responses, as well as sustained CTL responses. Recently, molecular techniques have provided fundamental insights into the molecular mechanisms of the immune system for HCV infection [Citation16, Citation18]. In 1996, Nowak and Bangham [Citation15] proposed a simple mathematical model to explore the relation between antiviral immune response and virus load. In 2003, Wodarz [Citation22] extended the model in [Citation15] to investigate the role of CTL and antibody response in HCV infection dynamics and pathology. Zhou et al. [Citation24, Citation25] considered the CTL immune response against HCV infection. However, the mechanism of CTL action in HCV infection is still not fully understood [Citation6, Citation9].
Mathematical models have become important tools in analysing the spread and control of HCV epidemic. Dahari et al. [Citation4] constructed a few within-host HCV infection models to describe HCV viral dynamics from the beginning of the anhepatic phase until the first viral increase data point. These models included two compartments of infection, but did not describe the asymptotical viral dynamics after transplantation of the liver. Qesmi et al. [Citation17] proposed a mathematical model of ordinary differential equations to describe the dynamics of the HBV/HCV and its interaction with both liver and blood cells based on [Citation4, Citation13], and found that the system undergoes either a transcritical or a backward bifurcation. Wodarz and Jansen [Citation23] proposed a model containing infected cells, non-acitived antigen presenting cells (APCs), acitived APCs and CTL, and analysed its complex dynamics.
However, there are very few HCV infection models with two compartments. Based on the existence of a second replication compartment for HCV and the role of CTL immune response against HCV infection, in this paper, we propose a new mathematical model containing another compartment of HCV infection. Then by the analysis of golbal dynamics, these theoretical results will reveal the interaction between HCV and CLT immune response more completely.
This paper is organized as follows. In Section 2, we formulate a new HCV infection model with CTL immune response and give a positively invariant set. Section 3 deals with the existence of equilibria for the model and two important parameters thresholds will be defined. In Section 4, the global stability of equilibria is investigated by using the Routh-Hurwitz criterion and Lyapunov functions. Some numerical examples are shown in Section 5. Finally, the epidemiological meanings of the obtained results are discussed, and the basic reproduction numbers of HCV infection and CTL immune response are given in Section 6.
2. Model formulation
In this section, we formulate a dynamical model with two proliferative compartments of HCV, one of which is the liver, the other is the extrahepatic compartment including serum, peripheral blood mononuclear cells (PBMC), and perihepatic lymph nodes (PLN). No experiments have shown that CTL immune response has effect or no effect on the extrahepatic compartment, here, it is assumed that the CTL immune response takes part in clearing infected hepatocytes and plays no role for the second proliferative compartment. The flowchart of HCV infection is shown in Figure . Here, we denote the liver and the second proliferative compartment (extrahepatic compartment) as compartments and
, respectively. In compartment
, there are uninfected hepatocytes
infected hepatocytes
and the CTL immune response
In compartment
, there are uninfected extrahepatic cells
infected extrahepatic cells
and free virus
Following the transmission diagram in Figure , our model takes the form in (Equation1
(1)
(1) )
(1)
(1) Here,
is the recruitment rate of healthy cells and
is the average lifespan of uninfected cells in compartment
The healthy cells become infected by free virus at a rate
; infected cells in compartment
die at a rate
, and infected cells in compartment
are cleared by the CTL immune response at a rate
; the CTL immune response is triggered at a rate
, which in turn decays a rate rz. We assume that the parameters are positive and
[Citation14] according to the biological meaning. Note that a saturated nonlinear function was used in Wodarz and Jansen [Citation23] to describe the activation of the CTL immune response by the virus. Since we are interested in the global dynamics of the model, for the sake of simplicity we use a linear function here.
Figure 1. Flowchart of the viral infection model with CTL immune response in intrahepatic and extrahepatic compartments.
![Figure 1. Flowchart of the viral infection model with CTL immune response in intrahepatic and extrahepatic compartments.](/cms/asset/e68433d1-56b3-43cb-b825-2a5c1d0b4023/tjbd_a_1859632_f0001_ob.jpg)
We can see that solutions of model (Equation1(1)
(1) ) with the nonnegative initial conditions remain nonnegative. From the first equation of (Equation1
(1)
(1) ), we have
then
From the first two equations of (Equation1
(1)
(1) ), we obtain
since
, then
Similarly, from the middle two equations of (Equation1
(1)
(1) ), we have
, and
.
When , from the fifth equation of (Equation1
(1)
(1) ) we have
then
And z = 0 always satisfies the last equation in (Equation1
(1)
(1) ). Therefore, the region
is positively invariant with respect to system (Equation1
(1)
(1) ). Therefore, it is sufficient to study the dynamics of model (Equation1
(1)
(1) ) with initial conditions in Ω.
3. Existence of equilibria
In this section, we discuss the existence of equilibria of model (Equation1(1)
(1) ) satisfying the following equations
(2)
(2) on the set Ω.
Model (Equation1(1)
(1) ) always has an infection-free equilibrium
, where
. From the first and third equations of (Equation2
(2)
(2) ), we obtain
(3)
(3) Substituting them into the second and fourth equations of (Equation2
(2)
(2) ), they yields respectively
(4)
(4) When
and z = 0, substituting
and
of (Equation4
(4)
(4) ) into the fifth equation of (Equation2
(2)
(2) ) yields
(5)
(5) We can see that function
is decreasing with respect to v. Note that
where
is used. Since the inequality
holds for m, n>0 if and only if mn>1, we know that
. Thus, by the monotonicity of function
, Equation (Equation5
(5)
(5) ) has a unique positive root
only when
. Furthermore, the corresponding
and
(i = 1, 2) can be obtained from (Equation3
(3)
(3) ) and (Equation4
(4)
(4) ). Thus, (Equation1
(1)
(1) ) has a boundary equilibrium
when
.
When , from the last equation of (Equation2
(2)
(2) ) we have
. Substituting it and
in (Equation3
(3)
(3) ) into the second equation of (Equation2
(2)
(2) ) gives
(6)
(6) Then a necessary condition on the existence of the positive equilibrium is
, and, for the positive equilibrium
,
.
On the other hand, substituting and
in (Equation3
(3)
(3) ) into the fifth equation of (Equation2
(2)
(2) ) yields
(7)
(7) Under the case that
(i.e.
) and for
(i = 1, 2), we have
Applying again the inequality that
holds for m, n>0 if and only if mn>1, we know that
. Then, according to the monotonicity of function
, the fact that
implies that equation
has a unique root in the interval
if and only if
Note that
as
. Then there must exist a boundary equilibrium
if the positive equilibrium
exists.
We claim that for ,
is equivalent to the inequality
i.e.
In fact, since
is the root of equation
, then the monotonicity of
implies that
as
On the other hand, direct calculation shows that
. Hence, according the existence of the equilibrium
, model (Equation1
(1)
(1) ) has a unique positive equilibrium
as
,
and
i.e.
.
Notice that, when ,
implies that
. Then, summarizing the above discussion, we have the following theorem.
Theorem 3.1
Denote
The existence of equilibria in system (Equation1
(1)
(1) ) can be summarized below.
(a) | The infection-free equilibrium | ||||
(b) | When | ||||
(c) | When |
4. Stability of equilibria
In this section, we discuss the global stability of equilibria of (Equation1(1)
(1) ). We first present two propositions for the infection-free equilibrium
.
Proposition 4.1
When , the infection-free equilibrium
is locally asymptotically stable; when
, it is unstable.
Proof.
The Jacobian matrix of system (Equation1(1)
(1) ) at
is
The eigenvalues of
are
,
,
, and the roots of the equation
(8)
(8) where
Since
implies that
we have
and
when
.
Furthermore, we have
as
. It follows from the Routh-Hurwitz criterion that all roots of (Equation8
(8)
(8) ) have negative real parts if
. Thus, the infection-free equilibrium
is locally asymptotically stable when
. Since
is equivalent to
, we know that
is unstable as
.
Proposition 4.2
When ,
Proof.
Since , we have
and
, that is,
and
. Moreover, direct calculation shows that
is equivalent to the following inequality
So we can choose a positive number
satisfying the inequality
(9)
(9) that is,
and
Further, for the given
, we choose a positive number
satisfying the inequality
(10)
(10) When
and
are given, we define a function
Then
and
imply that the derivative of
along solutions of model (Equation1
(1)
(1) ) is given by
It follows from (Equation9
(9)
(9) ) and (Equation10
(10)
(10) ) that
Then
Thus, we have
It implies that
, that is,
.
For the global stability of equilibria of (Equation1(1)
(1) ), we have the following results.
Theorem 4.1
When the infection-free equilibrium
of model (Equation1
(1)
(1) ) is globally stable in Ω; when
, the immune response-free equilibrium
of model (Equation1
(1)
(1) ) is globally stable in
; when
and
, the infection equilibrium
of model (Equation1
(1)
(1) ) is globally stable in the set Ω.
Proof.
When by Proposition 4.2 and the theory of asymptotic autonomous systems [Citation19, Theorem 1.2], it then follows from the first and third equations of (Equation1
(1)
(1) ) that
and
as
. Furthermore, Proposition 4.1 implies that the infection-free equilibrium
is globally stable in the set Ω when
.
Next, we consider the global stability of the equilibrium
. Define a Lyapunov function
then the derivative of
along solutions of system (Equation1
(1)
(1) ) is given by
Since
and
satisfy the following equations
then
can be rewritten as follows
Since the arithmetical mean is greater than or equal to the geometrical mean, for
, we have
and the equality holds if and only if
;
, and the equality holds if and only if
;
, and the equality holds if and only if
and
;
and the equality holds if and only if
and
.
Therefore, when , we have that
, and that the equality holds if and only if
,
, z = 0, and
. The largest invariant set of system (Equation1
(1)
(1) ) on the region
is the singleton
when
. Thus, it follows from LaSalle Invariance Principal [Citation10] that the boundary equilibrium
is globally asymptotically stable in the region Ω.
Lastly, we discuss the global stability of the positive equilibrium . Define a Lyapunov function
then the derivative of
along solutions of system (Equation1
(1)
(1) ) is given by
Using the equalities
,
,
,
,
, and
, we can rewrite
as follows:
Similar to the proof of the global stability of the equilibrium
, we have that
, and that the equality holds if and only if
,
, and
. In addition, the largest invariant set of system (Equation1
(1)
(1) ) on the set
is the singleton
when
. By LaSalle Invariance Principal [Citation10], the positive equilibrium
is globally asymptotically stable in the region Ω.
5. Numerical simulations
In the previous sections, we have investigated the existence and global stability of the equilibria through some theoretical analysis. In this section, we will carry out some numerical simulations of (Equation1(1)
(1) ) with parameter values
, except for γ and q. Initial values are fixed in Figure at
,
,
and
. We choose the different values of γ and q to represent different dynamic behaviours. These parameter values chosen here are consistent with those in the models [Citation12, Citation22, Citation23].
Figure 2. The infection-free equilibrium is globally asymptotically stable, here
and q = 0.1. The other parameter values are fixed as
, and then
.
![Figure 2. The infection-free equilibrium E0 is globally asymptotically stable, here γ=5 and q = 0.1. The other parameter values are fixed as λ1=1,β1=0.08,d1=0.2,a1=0.2,p=0.3,λ2=0.8,β2=0.1,d2=0.2,a2=0.2,k1=1,k2=1.2,r=0.2, and then R01=0.88<1.](/cms/asset/dbf06468-36b2-4637-a84f-38153381855e/tjbd_a_1859632_f0002_oc.jpg)
Figure 3. The immune response-free equilibrium is globally asymptotically stable, here
and q = 0.06. The other parameter values are identical with those in Figure , and then
and
.
![Figure 3. The immune response-free equilibrium E1 is globally asymptotically stable, here γ=2 and q = 0.06. The other parameter values are identical with those in Figure 2, and then R01=2.2>1 and R02=0.7729<1.](/cms/asset/0ff8133f-ad22-4bf6-83cc-1aff4f75e839/tjbd_a_1859632_f0003_oc.jpg)
Figure 4. The infection equilibrium is globally asymptotically stable, here
and q = 0.1. The other parameter values are identical with those in Figure , and then
and
.
![Figure 4. The infection equilibrium E2 is globally asymptotically stable, here γ=2 and q = 0.1. The other parameter values are identical with those in Figure 2, and then R01=2.2>1 and R02=1.2882>1.](/cms/asset/5863f163-fd31-4903-95ff-5d481d59448f/tjbd_a_1859632_f0004_oc.jpg)
When and q = 0.1, we calculate
. From Theorem 4.1, it follows that the equilibrium
of model (Equation1
(1)
(1) ) is globally asymptotically stable (see Figure ). When
and q = 0.06, we obtain
and
From Theorem 4.1, we know that the equilibrium
of model (Equation1
(1)
(1) ) is globally asymptotically stable (see Figure ). In Figure , with parameters
and q = 0.1, the thresholds
and
. The infection equilibrium
of model (Equation1
(1)
(1) ) is globally asymptotically stable, which is consistent with Theorem 4.1.
6. Conclusion and discussion
The novelty of our study is that we introduced a new compartment (extrahepatic compartment)) into the classical within-host hepatitis C virus infection models (see Wozard and Jansen [Citation23]) and provided results on the gobal dynamics of the model. According to Theorems 3.1 and 4.1, and
are two thresholds determining the dynamical behaviours of system (Equation1
(1)
(1) ) (see Figure ). When
system (Equation1
(1)
(1) ) has a unique equilibrium
, which is globally stable in the set Ω; when
, besides the boundary equilibrium
, system (Equation1
(1)
(1) ) also has another boundary equilibrium
, which is globally stable in the set Ω; when
, in addition to the boundary equilibria
and
, system (Equation1
(1)
(1) ) has a unique infection equilibrium
which is globally stable in the set Ω.
Notice that
is the basic reproduction number of Hepatitis C virus infection within the host. In fact,
is the number of healthy cells at the steady state in compartment
in the absence of infection,
is the number of new infected cells in unit time by per capital virion in compartment
,
is the number of new released virion by an infected cell,
is the average infectious period of virus, then
is the basic reproduction number of Hepatitis C virus within compartment
. Similarly,
is the one within compartment
.
Notice that although is the threshold determining the existence and stability of the positive equilibrium
, it is not the basic reproduction number. From Theorem 3.1,
, denoted by
, can also be thought as a threshold when
, which plays the same role as the threshold
in determining the dynamical behaviours of system (Equation1
(1)
(1) ). Since
is the number of infected cells in compartment
at the steady state when
,
is the CTL immune response existed in a unit time by per CTL response, and
is the average decaying period of CTL response, then
represents the basic reproduction number of the CTL immune response.
For system (Equation1(1)
(1) ), we have discussed the existence and stability of three equilibria
,
and
. In the sense of viral dynamics, the boundary equilibrium
represents the infection-free steady state within the host; the other boundary equilibrium
represents the steady state at which the host is infected, and the CTL immune response plays no role in protecting the host from infection; the positive equilibrium
represents the steady state at which the host is infected and the CTL immune response plays a certain role in protecting the host from infection, but it cannot clear completely the infected cells in compartment
. Therefore, by Theorems 3.1 and 4.1, when
, the virus will be cleared eventually and the CTL immune response also disappears; when
, the virus persists within the host, but the CTL immune response disappears eventually, this implies that the immune system in the body of patient has no effect on neutralizing the infection of the virus; when
, both the virus and the CTL immune response persist within the host, but the CTL immune response does not suffice to clear the virus completely.
According to the expression of the basic reproduction number of the CTL response , increasing the coefficient of producing the CTL response q implies the increase of
. Since increasing the value of q results in the decrease of the values of
,
and
for the infetion equilibrium
, increasing the ability of producing the CTL response can relieve the infetion from viruses.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
References
- http://www.who.int/bulletin/volumes/88/11/10-011110/en/index.html.
- M.J. Alter, H.S. Margolis, K. Krawczynski, F.N. Judson, A. Mares, W.J. Alexander, P.Y. Hu, J.K. Miller, M.A. Gerber, R.E. Sampliner, E.L. Meeks, and M.J. Beach, The natural history of community-acquired hepatitis C in the United States, N. Engl. J. Med. 327 (1992), pp. 1899–1905.
- M. Carrozzo, R. Quadri, P. Latorre, M. Pentenero, S. Paganin, G. Bertolusso, S. Gandolfo, and F.Negro, Molecular evidence that the hepatitis C virus replicates in the oral mucosa, J. Hepatol. 37 (2002), pp. 364–369.
- H. Dahari, A. Feliu, M. Garcia-Retortillo, X. Forns, and A.U. Neumann, Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation, J. Hepatol. 42 (2005), pp. 491–498.
- S. De Vita, V. De Re, D. Sansonno, D. Sorrentino, R.L. Corte, B. Pivetta, D. Gasparotto, V. Racanelli, A. Marzotto, A. Labombarda, A. Gloghini, G. Ferraccioli, A. Monteverde, A. Carbone, F. Dammacco, and M. Boiocchi, Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis, Hepatology 31 (2000), pp. 182–189.
- P. Farci, A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J.C. Melpolder, A. Strazzera, D.Y. Chien, S.J.Munoz, A. Balestrieri, R.H. Purcell, and H.J. Alter, The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies, Science. 288 (2000), pp. 339–344.
- T.L. Fong, M. Shindo, S.M. Feinstone, J.H. Hoofnagle, and A.M. Di Bisceglie, Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C, J. Clin. Invest. 88 (1991), pp. 1058–1060.
- J.H. Hoofnagle, Management of hepatitis C: current and future perspectives, J. Hepatol 31 (1999), pp. 264–268.
- P. Klenerman, F. Lechner, M. Kantzanou, A. Ciurea, H. Hengartner, and R. Zinkernagel, Viral escape and the failure of cellular immune responses, Science. 289 (2000), p. 2003.
- J.P. LaSalle, The Stability of Dynamical Systems, SIAM, Philadelphia, 1976.
- T. Laskus, M. Radkowski, J. Wilkinson, H. Vargas, and J. Rakela, The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus, J. Infect. Dis. 185 (2002), pp. 417–421.
- J. Li, K. Men, Y. Yang, and D. Li, Dynamical analysis on a chronic hepattis C virus infection model with immune response, J. Theoret. Biol. 365 (2015), pp. 337–346.
- Y. Liu and X. Liu, Global properties and bifurcation analysis of an HIV-1 infection model with two target cells, Comp. Appl. Math. 37 (2018), pp. 3455–3472.
- A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, T.J. Layden, and A.S. Perelson, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy, Science. 282 (1998), pp. 103–107.
- M.A. Nowak and C.R.M. Bangham, Population dynamics of immune responses to persistent viruses, Science. 272 (1996), pp. 74–79.
- A. Plauzolles, M. Lucas, and S. Gaudieri, Hepatitis C virus adaptation to T-cell immune pressure, Sci. World J. 2013 (2013), Article ID 673240.
- R. Qesmi, J. Wu, J. Wu, and J.M. Heffernan, Influence of backward bifurcation in a model of hepatitis B and C viruses, Math. Biosci. 224 (2010), pp. 118–125.
- S.D. Sharma, Hepatitis C virus: molecular biology and current therapeutic options, Indian J. Med. Res. 131 (2010), pp. 17–34.
- H.R. Thieme, Convergence results and a Poincaré-Bendison trichotomy for asymptotical autonomous differential equations, J. Math. Biol. 30 (1992), pp. 755–763.
- M. Tsiang, J. Rooney, J. Toole, and C. Gibbs, Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy, Hepatology 29 (1999), pp. 1863–1869.
- WHO, Global Hepatitis Report, 2017. France: WHO; 2017.
- D. Wodarz, Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses, J. Gen. Virol. 84 (2003), pp. 1743–1750.
- D. Wodarz and V.A.A. Jansen, A dynamical perspective of CTL cross-priming and regulation: implications for cancer immunology, Immunol. Lett. 86 (2003), pp. 213–227.
- X. Zhou, X. Shi, Z. Zhang, and X. Song, Dynamical behavior of a virus dynamics model with CTL immune response, Appl. Math. Comput. 213 (2009), pp. 329–347.
- Y. Zhou, Y. Zhang, Z. Yao, J.P. Moorman, and Z. Jia, Dendritic cell-based immunity and vaccination agains the patitis C virus infection, Immunology 136 (2012), pp. 385–396.